Burjeel Holdings, a leading super-specialty healthcare services provider in the MENA region, is set to take center stage at Abu Dhabi Global Health Week (ADGHW) 2025 as the Official Healthcare Transformation Partner.
Revolving around the theme ‘Leading the Shift. Powering the Breakthroughs’, the Group will highlight an integrated innovation ecosystem, delivering smarter, faster, and more compassionate care across communities.
During the event, set to take place from April 15 to 17, Burjeel Holdings will welcome global delegates to Booth A030, providing an immersive experience into the future of healthcare. Spanning AI, complex care, precision diagnostics, and space medicine, the Group is pioneering a new era of healthcare delivery, focused on advanced care and a commitment to meaningful patient outcomes.
One of the major highlights is Burjeel’s groundbreaking approach to cancer care, anchored in the official launch of its CAR-T cell therapy program. By integrating cutting-edge science with a dedication to equity, Burjeel is advancing oncology research and access, particularly for underserved populations.
Burjeel Cancer Institute will also announce a series of strategic collaborations with leading institutions, including the Children’s Hospital of Philadelphia (CHOP), SJD Barcelona Children’s Hospital, Ohio State University Wexner Medical Center, and Great Ormond Street Hospital, aimed at enhancing pediatric and adult cancer treatment pathways.
AI and diagnostics; Driving innovation
The Group will also introduce an AI-powered empathic Nursing Solution, an innovation designed to augment the nursing force, to showcase the future of patient experience. Visitors will get an in-depth insights into Burjeel’s implementation of Oracle’s AI-driven Electronic Medical Record (EMR) platform.
The live demonstrations of next-generation point-of-care technologies and panels featuring global experts will focus on how early detection, and rapid diagnostics can be reimagined to create timely, personalized, and precise care pathways.
Rather than simply adopting external technologies, Burjeel Holdings is collaborating with its partners to co-develop solutions that reflect the cultural, clinical, and infrastructural realities of the region.
The group’s integrated approach addresses a key challenge in healthcare—fragmentation. By building cross-functional synergies across the entire patient journey, from prevention and diagnosis to treatment and follow-up, Burjeel is delivering a model of care that is not only more accessible but also more comprehensive, coordinated, and sustainable.
John Sunil CEO – Burjeel Holdings
“As the official Healthcare Transformation Partner of Abu Dhabi Global Health Week, we are proud to showcase innovations that not only push the boundaries but are also rooted in equity, accessibility, and patient-centricity. Together with our global partners, we are building an ecosystem that democratizes advanced care and redefines what’s possible in healthcare for our region and beyond.”
Exploring the power of data and research
Burjeel’s pavilion will unlock the power of real-world data in shaping tomorrow’s healthcare. The Group will offer insights from its ongoing global Phase 3 clinical trials, while spotlighting Abu Dhabi’s emergence as a hub for clinical research, precision medicine, and biotech innovation.
Furthermore, Burjeel Holdings will spotlight its research with Axiom Space under a special session titled ‘Space Is the Limit: Redefining Medicine for Earth and Beyond,’ exploring ways to make space missions accessible to astronauts with diabetes.
The Group will also carry out high-impact conversations, thought-leadership forums, and innovation showcases, strengthening its commitment to patient-centered progress and redefining what’s possible in healthcare.
